Suppr超能文献

马达加斯加肝硬化急性失代偿患者院内死亡的相关因素:一项回顾性队列研究

Factors Associated with in-Hospital Mortality in Malagasy Patients with Acute Decompensation of Liver Cirrhosis: A Retrospective Cohort.

作者信息

Razafindrazoto Chantelli Iamblaudiot, Randriamifidy Nitah Harivony, Ralaizanaka Behoavy Mahafaly, Andrianoelison Jean Tsitamita, Ravelomanantsoa Haga Tsilavo, Rakotomaharo Mialitiana, Hasina Laingonirina Domoina Harivonjy, Maherison Sonny, Rakotomalala Jolivet Auguste, Rasolonjatovo Anjaramalala Sitraka, Rakotozafindrabe Andry Lalaina Rinà, Rabenjanahary Tovo Harimanana, Razafimahefa Soloniaina Hélio, Ramanampamonjy Rado Manitrala

机构信息

Gastroenterology Unit, University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar.

Hepato-Gastroenterology Unit, University Hospital Andrainjato, Fianarantsoa, Madagascar.

出版信息

Hepat Med. 2023 Mar 12;15:21-26. doi: 10.2147/HMER.S401628. eCollection 2023.

Abstract

BACKGROUND

Cirrhosis is a pathology responsible for a significant hospital morbidity and mortality. The objective of this study was to determine the factors associated with hospital mortality in a sample of Malagasy cirrhotics.

PATIENTS AND METHODS

This was a retrospective cohort study from January 2018 to August 2020 conducted in the Hepato-Gastroenterology Unity, University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar.

RESULTS

One hundred and eight patients were included. The mean age was 51.13±13.50 years with a sex ratio of 2.37. The etiology of cirrhosis was dominated by alcohol (44.44%), hepatitis B virus (24.07%) and hepatitis C virus (13.89%). Twenty-eight patients (25.93%) had died. Factors associated with in-hospital mortality were hepatic encephalopathy (OR: 14.16; 95% CI: 5.08-39.4; p: 0.000), renal failure (OR: 8.55; 95% CI: 2.03-39.9; p: 0.0034), gastrointestinal bleeding (OR: 3.25; 95% CI: 1.32-7.92; p: 0.0099), hyponatraemia <130mmol/L (OR: 3.34; 95% CI: 1.04-10.6; p=0.046), Child-Pugh C classification (OR: 0.19; 95% CI: 0.12-0.21; p: 0.000), and MELD-Na score >32 (OR: 27.5; 95% CI: 4.32-174.8; p: 0.004).

CONCLUSION

The in-hospital mortality rate during acute decompensation of cirrhosis remains high in Madagascar. Hepatic encephalopathy, renal failure, GI bleeding and hyponatraemia are the main clinico-biological factors affecting in-hospital mortality. Early intervention on these modifiable factors is an important step to improve hospital outcomes. The natraemia, MELD score and MELD-Na score should be used in routine practice in Madagascar to identify patients with acute decompensation of cirrhosis at high risk of death.

摘要

背景

肝硬化是导致医院内高发病率和死亡率的一种病理状态。本研究的目的是确定马达加斯加肝硬化患者样本中与医院死亡率相关的因素。

患者与方法

这是一项于2018年1月至2020年8月在马达加斯加塔那那利佛约瑟夫·拉塞塔·贝费拉塔纳纳大学医院肝病胃肠病科进行的回顾性队列研究。

结果

共纳入108例患者。平均年龄为51.13±13.50岁,性别比为2.37。肝硬化的病因以酒精性(44.44%)、乙型肝炎病毒(24.07%)和丙型肝炎病毒(13.89%)为主。28例患者(25.93%)死亡。与住院死亡率相关的因素有肝性脑病(比值比:14.16;95%置信区间:5.08 - 39.4;p:0.000)、肾衰竭(比值比:8.55;95%置信区间:2.03 - 39.9;p:'0.0034)、胃肠道出血(比值比:3.25;95%置信区间:1.32 - 7.92;p:0.0099)、血钠<130mmol/L(比值比:3.34;95%置信区间:1.04 - 10.6;p = 0.046)、Child-Pugh C级分类(比值比:0.19;95%置信区间:0.12 - 0.21;p:0.000)以及终末期肝病模型钠评分>32(比值比:27.5;95%置信区间:4.32 - 174.8;p:0.004)。

结论

在马达加斯加,肝硬化急性失代偿期的住院死亡率仍然很高。肝性脑病、肾衰竭、胃肠道出血和低钠血症是影响住院死亡率的主要临床生物学因素。对这些可改变因素进行早期干预是改善医院治疗效果的重要一步。在马达加斯加的常规实践中,应使用血钠、终末期肝病模型评分和终末期肝病模型钠评分来识别肝硬化急性失代偿且死亡风险高的患者。

相似文献

本文引用的文献

4
Burden of liver diseases in the world.世界范围内的肝脏疾病负担。
J Hepatol. 2019 Jan;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014. Epub 2018 Sep 26.
5
[Hyponatremia in Liver Cirrhosis].[肝硬化中的低钠血症]
Korean J Gastroenterol. 2018 Aug 25;72(2):74-78. doi: 10.4166/kjg.2018.72.2.74.
7
Hospital resource intensity and cirrhosis mortality in United States.美国医院资源强度与肝硬化死亡率
World J Gastroenterol. 2017 Mar 14;23(10):1857-1865. doi: 10.3748/wjg.v23.i10.1857.
10
In-hospital mortality risk factors in patients with ascites due to cirrhosis.
Rev Assoc Med Bras (1992). 2015 Jan-Feb;61(1):35-9. doi: 10.1590/1806-9282.61.01.035. Epub 2015 Jan 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验